Suppr超能文献

持续性 NHE 激活可能是 COVID-19 细胞因子释放综合征的原因和结果。

Prolonged NHE Activation may be both Cause and Outcome of Cytokine Release Syndrome in COVID-19.

机构信息

Department of Biochemistry, Private Tanfer Hospital, Istanbul, Turkey.

Department of Internal Medicine, Bagcilar Medilife Hospital, Istanbul, Turkey.

出版信息

Curr Pharm Des. 2022;28(22):1815-1822. doi: 10.2174/1381612828666220713121741.

Abstract

The release of cytokines and chemokines such as IL-1β, IL-2, IL-6, IL-7, IL-10, TNF-α, IFN-γ, CCL2, CCL3, and CXCL10 is increased in critically ill patients with COVID-19. Excessive cytokine release during COVID-19 is related to increased morbidity and mortality. Several mechanisms are put forward for cytokine release syndrome during COVID-19. Here we have mentioned novel pathways. SARS-CoV-2 increases angiotensin II levels by rendering ACE2 nonfunctional. Angiotensin II causes cytokine release via AT and AT receptors. Moreover, angiotensin II potently stimulates the Na+/H+ exchanger (NHE). It is a pump found in the membranes of many cells that pumps Na+ inward and H+ outward. NHE has nine isoforms. NHE1 is the most common isoform found in endothelial cells and many cells. NHE is involved in keeping the intracellular pH within physiological limits. When the intracellular pH is acidic, NHE is activated, bringing the intracellular pH to physiological levels, ending its activity. Sustained NHE activity is highly pathological and causes many problems. Prolonged NHE activation in COVID-19 may cause a decrease in intracellular pH through H+ ion accumulation in the extracellular area and subsequent redox reactions. The activation reduces the intracellular K+ concentration and leads to Na+ and Ca overload. Increased ROS can cause intense cytokine release by stimulating NF-κB and NLRP3 inflammasomes. Cytokines also cause overstimulation of NHE. As the intracellular pH decreases, SARS-CoV-2 rapidly infects new cells, increasing the viral load. This vicious circle increases morbidity and mortality in patients with COVID-19. On the other hand, SARS-CoV-2 interaction with NHE3 in intestinal tissue is different from other tissues. SARS-CoV-2 can trigger CRS via NHE3 inhibition by disrupting the intestinal microbiota. This review aimed to help develop new treatment models against SARS-CoV-2- induced CRS by revealing the possible effects of SARS-CoV-2 on the NHE.

摘要

COVID-19 重症患者的细胞因子和趋化因子(如 IL-1β、IL-2、IL-6、IL-7、IL-10、TNF-α、IFN-γ、CCL2、CCL3 和 CXCL10)释放增加。COVID-19 期间过度的细胞因子释放与发病率和死亡率增加有关。提出了 COVID-19 期间细胞因子释放综合征的几种机制。在这里,我们提到了新的途径。SARS-CoV-2 通过使 ACE2 失去功能来增加血管紧张素 II 的水平。血管紧张素 II 通过 AT 和 AT 受体引起细胞因子释放。此外,血管紧张素 II 强烈刺激 Na+/H+交换器(NHE)。它是一种在许多细胞的膜中发现的泵,将 Na+向内和 H+向外泵出。NHE 有九个同工型。NHE1 是在内皮细胞和许多细胞中发现的最常见同工型。NHE 参与将细胞内 pH 保持在生理范围内。当细胞内 pH 呈酸性时,NHE 被激活,使细胞内 pH 恢复到生理水平,从而结束其活性。持续的 NHE 活性是高度病理性的,并导致许多问题。COVID-19 中 NHE 的持续激活可能会通过在细胞外区域积聚 H+离子并随后发生氧化还原反应导致细胞内 pH 降低。这种激活降低了细胞内 K+浓度并导致 Na+和 Ca 过载。增加的 ROS 可以通过刺激 NF-κB 和 NLRP3 炎性小体引起强烈的细胞因子释放。细胞因子也会过度刺激 NHE。随着细胞内 pH 值的降低,SARS-CoV-2 迅速感染新细胞,增加病毒载量。这种恶性循环增加了 COVID-19 患者的发病率和死亡率。另一方面,SARS-CoV-2 与肠道组织中的 NHE3 的相互作用与其他组织不同。SARS-CoV-2 可以通过破坏肠道微生物群来抑制 NHE3 来触发 CRS。本综述旨在通过揭示 SARS-CoV-2 对 NHE 的可能影响,帮助开发针对 SARS-CoV-2 诱导的 CRS 的新治疗模型。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验